Predicting outcomes following hospitalization for acute exacerbations of COPD

QJM: An International Journal of Medicine

Volumn 103, Issue 11, 2010, Pages 817-829

  Steer, J ^a   Gibson, G J ^b   Bourke, S C ^a,b  

^a NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ACIDEMIA; ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ARTERIAL GAS; CHRONIC KIDNEY FAILURE; CHRONIC LIVER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CINAHL; CLINICAL DECISION MAKING; COMORBIDITY; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; DISEASE EXACERBATION; DRUG MEGADOSE; EMBASE; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERCAPNIA; HYPOXEMIA; INFLUENZA; INTENSIVE CARE UNIT; ISCHEMIC HEART DISEASE; LONG TERM CARE; LUNG EDEMA; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PALLIATIVE THERAPY; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SHOCK; SMOKING; SOCIAL SUPPORT; SPIROMETRY; STROKE; SYSTEMATIC REVIEW;

EID: 78649351049     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcq126     Document Type: Review

References (114)

1. Office for National Statistics. In: Office for National Statistics, ed. Health Statistics Quarterly. Basingstoke, Hampshire, Palgrave MacMillan, 2006:1-62.
2. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.com.
3. Guest JF. The annual cost of chronic obstructive pulmonary disease to the UK's National Health Service. Dis Manag Health Out 1999; 5:93-101.
4. O'Reilly JF, Williams AE, Rice L. Health status impairment and costs associated with COPD exacerbation managed in hospital. Int J Clin Practice 2007; 61:1112-20.
5. Burge S, Wedzicha JA. COPD exacerbations: Definitions and classifications. Eur Respir J Suppl 2003; 41:46s-53s.
6. Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai-Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:369-74.
7. Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000; 117:662-71.
8. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Int Med 2003; 163:1180-6.
9. Ai-Ping C, Lee KH, Lim TK. In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study. Chest 2005; 128:518-24.
10. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007; 132:1748-55.
11. Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124:459-67.
12. Chu CM, Chan VL, Lin AW, Wong IW, Leung WS, Lai CK. Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 2004; 59:1020-5.
13. Chambellan A, Chailleux E, Similowski T, Group AO. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128:1201-8.
14. Foucher P, Baudouin N, Merati M, Pitard A, Bonniaud P, Reybet-Degat O, et al. Relative survival analysis of 252 patients with COPD receiving long-term oxygen therapy. Chest 1998; 113:1580-7.
15. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New Eng J Med 2004; 350:1005-12.
16. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374:704-11.
17. Wildman MJ, Harrison DA, Welch CA, Sanderson C. A new measure of acute physiological derangement for patients with exacerbations of obstructive airways disease: the COPD and Asthma Physiology Score. Respir Med 2007; 101:1994-2002.
18. Wildman MJ, Sanderson C, Groves J, Reeves BC, Ayres J, Harrison D, et al. Predicting mortality for patients with exacerbations of COPD and Asthma in the COPD and Asthma Outcome Study (CAOS). QJM 2009; 102:389-99.
19. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) [erratum appears in Am J Respir Crit Care Med 1997; 155:386]. Am J Respir Crit Care Med 1996; 154(4 Pt 1):959-67.
20. Roche N, Zureik M, Soussan D, Neukirch F, Perrotin D, Urgence BSC. Predictors of outcomes in COPD exacerbation cases presenting to the emergency department. Eur Respir J 2008; 32:953-61.
21. Mohan A, Bhatt SP, Mohan C, Arora S, Luqman-Arafath TK, Guleria R. Derivation of a prognostic equation to predict in-hospital mortality and requirement of invasive mechanical ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2008; 50:335-42.
22. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794-800.
23. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-82.
24. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infec Dis 2007; 44(Suppl 2):S27-72.
25. Bustamante-Fermosel A, De Miguel-Yanes JM, Duffort-Falco M, Munoz J. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features. Am J Emerg Med 2007; 25:515-22.
26. Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995; 98:272-7.
27. Fruchter O, Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology 2008; 13:851-5.
28. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274:1852-7.
29. Kim S, Clark S, Camargo CA Jr. Mortality after an emergency department visit for exacerbation of chronic obstructive pulmonary disease. COPD: J Chron Obstruct Pulmon Dis 2006; 3:75-81.
30. Raurich JM, Perez J, Ibanez J, Roig S, Batle S. In-hospital and 2-year survival of patients treated with mechanical ventilation for acute exacerbation of COPD. Arch Bronconeumol 2004; 40:295-300.
31. Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005; 26:234-41.
32. Faustini A, Marino C, D'Ippoliti D, Forastiere F, Belleudi V, Perucci CA. The impact on risk-factor analysis of different mortality outcomes in COPD patients. Eur Respir J 2008; 32:629-36.
33. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34:491-6.
34. Ranieri P, Bianchetti A, Margiotta A, Virgillo A, Clini EM, Trabucchi M. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation. J Am Geriatr Soc 2008; 56:909-13.
35. Fruchter O, Yigla M. Cardiac troponin-i predicts long-term mortality in chronic obstructive pulmonary disease. COPD: J Chron Obstruct Pulmon Dis 2009; 6:155-61.
36. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:961-6.
37. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27:689-96.
38. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:591-7.
39. Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005; 128:2108-15.
40. Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-8.
41. Dransfield MT, Rowe SM, Johnson JE, Bailey WC, Gerald LB. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax 2008; 63:301-5.
42. Soyseth V, Brekke PH, Smith P, Omland T. Statin use is associated with reduced mortality in COPD. Eur Respir J 2007; 29:279-83.
43. Brekke PH, Omland T, Holmedal SH, Smith P, Soyseth V. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008; 31:563-70.
44. Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007; 101:1954-60.
45. Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brondum E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7.
46. Scala R, Bartolucci S, Naldi M, Rossi M, Elliott MW. Co-morbidity and acute decompensations of COPD requiring non-invasive positive-pressure ventilation. Intensive Care Med 2004; 30:1747-54.
47. Afessa B, Morales IJ, Scanlon PD, Peters SG. Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit Care Med 2002; 30:1610-5.
48. Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect 2009; 58:417-24.
49. Liu H, Zhang TT, Ye J. Analysis of risk factors for hospital mortality in patients with chronic obstructive pulmonary diseases requiring invasive mechanical ventilation. CMJ 2007; 120:287-93.
50. Sin DD, Tu JV. Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:580-4.
51. Ruiz-Gonzalez A, Lacasta D, Ibarz M, Martinez-Alonso M, Falguera M, Porcel JM. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Respirology 2008; 13:1028-33.
52. Goel A, Pinckney RG, Littenberg B. APACHE II predicts longterm survival in COPD patients admitted to a general medical ward. J Gen Intern Med 2003; 18:824-30.
53. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing 2002; 31:137-40.
54. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57:137-41.
55. Rivera-Fernandez R, Navarrete-Navarro P, Fernandez-Mondejar E, Rodriguez-Elvira M, Guerrero-Lopez F, Vazquez-Mata G, et al. Six-year mortality and quality of life in critically ill patients with chronic obstructive pulmonary disease. Crit Care Med 2006; 34:2317-24.
56. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Int Med 2007; 167:60-7.
57. Confalonieri M, Garuti G, Cattaruzza MS, Osborn JF, Antonelli M, Conti G, et al. A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation. Eur Respir J 2005; 25:348-55.
58. Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carre P, Perez T, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135:975-82.
59. de la Iglesia F, Diaz JL, Pita S, Nicolas R, Ramos V, Pellicer C, et al. Peak expiratory flow rate as predictor of inpatient death in patients with chronic obstructive pulmonary disease. South Med J 2005; 98:266-72.
60. Vitacca M, Clini E, Porta R, Foglio K, Ambrosino N. Acute exacerbations in patients with COPD: Predictors of need for mechanical ventilation. Eur Respir J 1996; 9:1487-93.
61. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 2009; 24:1043-8.
62. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J 2006; 28:346-51.
63. Bhatt SP, Khandelwal P, Nanda S, Stoltzfus JC, Fioravanti GT. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2008; 102:999-1003.
64. Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: A long term follow up study. Thorax 2002; 57:29-33.
65. Baillard C, Boussarsar M, Fosse JP, Girou E, Le Toumelin P, Cracco C, et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003; 29:584-9.
66. Chandra D, Guntupalli KK, Guleria R. Hypotension is a predictor of mortality in acute exacerbations of chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 2007; 49:13-8.
67. Plant PK, Owen JL, Elliott MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: Long term survival and predictors of in-hospital outcome. Thorax 2001; 56:708-12.
68. Putinati S, Ballerin L, Piattella M, Panella GL, Potena A. Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD? Respir Med 2000; 94:997-1001.
69. Chakrabarti B, Angus RM, Agarwal S, Lane S, Calverley PM. Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD. Thorax 2009; 64:857-62.
70. Ambrosino N, Foglio K, Rubini F, Clini E, Nava S, Vitacca M. Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: Correlates for success. Thorax 1995; 50:755-7.
71. Lieberman D, Lieberman D, Gelfer Y, Varshavsky R, Dvoskin B, Leinonen M, et al. Pneumonic vs nonpneumonic acute exacerbations of COPD. Chest 2002; 122:1264-70.
72. Chen Y, Stewart P, Dales R, Johansen H, Bryan S, Taylor G. In a retrospective study of chronic obstructive pulmonary disease inpatients, respiratory comorbidities were significantly associated with prognosis. J Clin Epidemiol 2005; 58:1199-205.
73. Ucgun I, Metintas M, Moral H, Alatas F, Yildirim H, Erginel S. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med 2006; 100: 66-74.
74. Khilnani GC, Banga A, Sharma SK. Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: A one year study. BMC Pulm Med 2004; 4:12.
75. Schettino G, Altobelli N, Kacmarek RM. Noninvasive positive pressure ventilation reverses acute respiratory failure in select "do-not-intubate" patients. Crit Care Med 2005; 33:1976-82.
76. Carratu P, Bonfitto P, Dragonieri S, Schettini F, Clemente R, Di Gioia G, et al. Early and late failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute exacerbation. Eur J Clin Invest 2005; 35:404-9.
77. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60:925-31.
78. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: A distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997; 102:239-44.
79. British Thoracic Society. Chronic Obstructive Pulmonary Disease Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London, National Clinical Guideline Centre, 2004.
80. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: Risk factors and use of guidelines for management. Thorax 1992; 47:34-40.
81. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006; 61:284-9.
82. Rammaert B, Verdier N, Cavestri B, Nseir S. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease. Respirology 2009; 14:969-74.
83. Jensen HH, Godtfredsen NS, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J 2006; 28:781-5.
84. Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, et al. A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 2009; 136:376-80.
85. Martins CS, Rodrigues MJO, Miranda VP, Nunes JPL. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Neth J Med 2009; 67:341-9.
86. Piccioni P, Caria E, Bignamini E, Forconi G, Nebiolo F, Arossa W, et al. Predictors of survival in a group of patients with chronic airflow obstruction. J Clin Epidemiol 1998; 51:547-55.
87. Rieves RD, Bass D, Carter RR, Griffith JE, Norman JR. Severe COPD and acute respiratory failure: Correlates for survival at the time of tracheal intubation. Chest 1993; 104:854-60.
88. Anton A, Guell R, Gomez J, Serrano J, Castellano A, Carrasco JL, et al. Predicting the result of noninvasive ventilation in severe acute exacerbations of patients with chronic airflow limitation. Chest 2000; 117:828-33.
89. Cook NR. Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin Chem 2008; 54:17-23.
90. Vestbo J, Rasmussen FV. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 1989; 2:710-5.
91. Briggs A, Spencer M, Wang H, Mannino D, Sin DD. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Int Med 2008; 168:71-9.
92. Mannino DM, Reichert MM, Davis KJ. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006; 173:985-90.
93. Tantucci C, Donati P, Nicosia F, Bertella E, Redolfi S, De Vecchi M, et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med 2008; 102:613-9.
94. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: Role of health status, anxiety and depression. Eur Respir J 2005; 26:414-9.
95. Ghanei M, Aslani J, Azizabadi-Farahani M, Assari S, Saadat SH. Logistic regression model to predict chronic obstructive pulmonary disease exacerbation. Arch Med Sci 2007; 3:360-6.
96. Wong AW, Gan WQ, Burns J, Sin DD, van Eeden SF. Acute exacerbation of chronic obstructive pulmonary disease: Influence of social factors in determining length of hospital stay and readmission rates. Can Respir J 2008; 15:361-4.
97. Murata GH, Gorby MS, Kapsner CO, Chick TW, Halperin AK. A multivariate model for predicting hospital admissions for patients with decompensated chronic obstructive pulmonary disease. Arch Int Med 1992; 152:82-6.
98. Almagro P, Barreiro B, Ochoa de Echaguen A, Quintana S, Rodriguez Carballeira M, Heredia JL, et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006; 73:311-7.
99. Lau AC, Yam LY, Poon E. Hospital re-admission in patients with acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2001; 95:876-84.
100. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM, et al. Risk factors of readmission to hospital for a COPD exacerbation: A prospective study. Thorax 2003; 58:100-5.
101. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11:188-95.
102. Vega Reyes JA, Montero Perez-Barquero M, Sanchez Guijo P. [Assessing COPD-associated morbidity: Factors of prognosis]. [Spanish] Factores pronosticos de reingreso en la enfermedad pulmonar obstructiva cronica. Medicina Clinica 2004; 122:293-7.
103. Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52:67-71.
104. Chen Y, Li Q, Johansen H. Age and sex variations in hospital readmissions for COPD associated with overall and cardiac comorbidity. IntJ Tuberc Lung Dis 2009; 13:394-9.
105. Velthove KJ, Souverein PC, van Solinge WW, Leufkens HGM, Lammers JWJ. Effects of corticosteroid use on readmission in obstructive lung disease. Respir Med 104:211-8.
106. Giron R, Matesanz C, Garcia-Rio F, de Santiago E, Mancha A, Rodriguez-Salvanes F, et al. Nutritional state during COPD exacerbation: Clinical and prognostic implications. Ann Nutr Metab 2009; 54:52-8.
107. Emtner MI, Arnardottir HR, Hallin R, Lindberg E, Janson C. Walking distance is a predictor of exacerbations in patients with chronic obstructive pulmonary disease. Respir Med 2007; 101:1037-40.
108. Gonzalez C, Servera E, Marin J. Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest 2008; 133:941-7.
109. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis and prognostic research: Validating a prognostic model. Br Med J 2009; 338:1432-5.
110. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55:1000-6.
111. Goodridge D, Lawson J, Duggleby W, Marciniuk D, Rennie D, Stang M. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med 2008; 102:885-91.
112. Curtis JR, Engelberg RA, Wenrich MD, Au DH. Communication about palliative care for patients with chronic obstructive pulmonary disease. J Palliat Care 2005; 21:157-64.
113. Esteban C, Quintana JM, Moraza J, Aburto M, Egurrola M, Espana PP, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med 2009; 103:1201-8.
114. Andenaes R, Moum T, Kalfoss MH, Wahl AK. Changes in health status, psychological distress, and quality of life in COPD patients after hospitalization. Qual Life Res 2006; 15:249-57.